Medical research

New tool PISA-REX facilitates drug development

Researchers have developed an industry-standard tool to facilitate drug development and translational research in collaboration between labs at Karolinska Institutet and the Gygi Lab at Harvard Medical School. Their results ...

Oncology & Cancer

Preclinical study explores approved drug for ovarian cancer

An iron-binding drug that is already approved for treatment of other diseases could provide a novel way to attack ovarian tumors, according to a new study led by Weill Cornell Medicine researchers. The preclinical study, ...

Oncology & Cancer

Q&A: Finding novel therapies for childhood cancer

Since the first time she treated a child with neuroblastoma, Giselle Saulnier Sholler wanted to do the impossible for her patients. Neuroblastoma is the most common extracranial solid tumor in children with roughly 700 new ...

page 1 from 26